Home About us Contact
|
Home About us Contact | ||
|
|
||
Therapy For Children (therapy + for_children)
Selected AbstractsJack Tizard Lecture: Cognitive Behaviour Therapies for Children: Passing Fashion or Here to Stay?CHILD AND ADOLESCENT MENTAL HEALTH, Issue 2 2005Philip Graham The aim of this article is to consider the current and likely future status of cognitive behaviour therapy (CBT) for disturbed children and adolescents. Two definitions of CBT, narrow and broad, are provided and their core components described. Subsequently the historical development of these therapies and their reception by psychotherapists with different orientations is discussed. Assessment and therapeutic CBT approaches are described and the strength of the evidence for their use is briefly reviewed. Finally the challenges these therapies are currently meeting that might enhance or diminish their value are outlined. It is concluded that CBTs offer a most promising approach in the child and adolescent field and are likely to establish and maintain an important place in the therapeutic armoury of the next generation of professionals concerned to help children and young people with psychiatric disorders. [source] The Effect of an Attachment-Based Behaviour Therapy for Children with Visual and Severe Intellectual DisabilitiesJOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, Issue 2 2008P. S. Sterkenburg Background, A combination of an attachment-based therapy and behaviour modification was investigated for children with persistent challenging behaviour. Method, Six clients with visual and severe intellectual disabilities, severe challenging behaviour and with a background of pathogenic care were treated. Challenging behaviour was recorded continuously in the residential home and during therapy sessions. Alternating treatments were given by two therapists. In phase 1, the experimental therapist attempted to build an attachment relationship in sessions alternating with sessions in which a control therapist provided positive attention only. In phase 2, both therapists applied the same behaviour modification protocol. Results, Across clients, challenging behaviour in the residential home decreased during the attachment therapy phase. The behaviour modification sessions conducted by the experimental therapist resulted in significantly more adaptive target behaviour than the sessions with the control therapist. Conclusion, For these clients with a background of attachment problems, attachment-based behaviour modification treatment may have important advantages over standard behaviour modification. [source] Obsessive-Compulsive Disorder in Children and AdolescentsCHILD AND ADOLESCENT MENTAL HEALTH, Issue 2 2001Roz Shafran Obsessive-compulsive disorder (OCD) is estimated to affect between 0.5% and 2% of children and adolescents. The majority of clinical cases has both obsessions and compulsions. Depression, anxiety and tic disorders are common comorbid diagnoses, and assessment can therefore be complex. Several theories have been proposed for the aetiology and maintenance of the disorder, including cognitive-behavioural and neuropsychiatric theories. Cognitive-behavioural and pharmacological treatments are both probably efficacious therapies for children and adolescents but further research is needed to compare these treatments with each other, and to examine the use of combination therapies in controlled trials. [source] Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemiaDEVELOPMENTAL DISABILITIES RESEARCH REVIEW, Issue 3 2006Peter D. Cole Abstract Most children diagnosed today with acute lymphoblastic leukemia (ALL) will be cured. However, treatment entails risk of neurotoxicity, causing deficits in neurocognitive function that can persist in the years after treatment is completed. Many of the components of leukemia therapy can contribute to adverse neurologic sequelae, including craniospinal irradiation, nucleoside analogs, corticosteroids, and antifolates. In this review, we describe the characteristic radiographic findings and neurocognitivie deficits seen among survivors of childhood ALL. We summarize what is known about the pathophysiology of delayed treatment-related neurotoxicity, with a focus on the toxicity resulting from pharmacologic disruption of folate physiology within the central nervous system. Finally, we suggest testable strategies to ameliorate the symptoms of treatment-related neurotoxicity or decrease its incidence. MRDD Research Reviews 2006;12:174,183. © 2006 Wiley-Liss, Inc. [source] Direct speech and language therapy for children with cerebral palsy: findings from a systematic reviewDEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 1 2005Lindsay Pennington PhD First page of article [source] Parental experience of participation in physical therapy for children with physical disabilitiesDEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 1 2003Lucres MC Jansen PhD First page of article [source] Forum on: the role of recombinant factor VIII in children with severe haemophilia AHAEMOPHILIA, Issue 2 2009M. FRANCHINI Summary., The development of recombinant FVIII (rFVIII) products, fuelled by the need for improved safety of treatment arising from the dramatic widespread blood-borne virus transmission in the 1970,1980s revolutionized the care of children with haemophilia A over the last two decades. The larger availability of perceived safer replacement therapy associated with the introduction of rFVIII products reassured the haemophilia community and there was a strong push in some Western countries to treat haemophilic children only with rFVIII. Moreover, this significantly contributed in the 1990s to the diffusion outside Northern Europe of prophylactic regimens implemented at an early age to prevent bleeding and the resultant joint damage (i.e. primary prophylaxis), together with the possibility of home treatment. These changes led to a substantial improvement of the quality of life of haemophilic children and of their families. The general agreement that primary prophylaxis represents the first-choice treatment for haemophilic children has been recently supported by two randomized controlled trials carried out with rFVIII products, providing evidence on the efficacy of early prophylaxis over on-demand treatment in preserving joint health in haemophilic children. However, the intensity and optimal modalities of implementation of prophylaxis in children, in particular with respect to the issue of the venous access, are still debated. A number of studies also supports the role of secondary prophylaxis in children, frequently used in countries in which primary prophylaxis was introduced more recently. With viral safety now less than an issue and with the more widespread use of prophylaxis able to prevent arthropathy, the most challenging complication of replacement therapy for children with haemophilia remains the risk of inhibitor development. Despite conflicting data, there is no evidence that the type of FVIII concentrate significantly influences the complex multifactorial process leading to anti-FVIII alloantibodies, whereas other treatment-related factors are likely to increase (early intensive treatments due to surgery or severe bleeds) or reduce (prophylaxis) the risk. Although the optimal regimen is still uncertain, eradication of anti-FVIII antibodies by immune tolerance induction (ITI), usually with the same product administered at inhibitor detection, should be the first-choice treatment for all patients with recent onset inhibitors. This issue applies particularly to children, as most patients undergo ITI at an early age, when inhibitors usually appear. The availability of a stable and long-lasting venous access represents a leading problem also in this setting. These and other topics concerning rFVIII treatment of haemophilic children were discussed in a meeting held in Rome on 27 February 2008 and are summarized in this report. [source] Showing you can do it: Homework in therapy for children and adolescents with anxiety disordersJOURNAL OF CLINICAL PSYCHOLOGY, Issue 5 2002Jennifer L. Hudson This article discusses the application of homework tasks in an empirically supported treatment for children (aged 8,13 years) with anxiety disorders. Within this program, homework tasks,through practice and rehearsal in the child's natural environment,are an important ingredient to enable the child to increase his or her mastery of the information/skills covered in each session. The homework tasks also provide an opportunity for the therapist to check the child's grasp of the session content through unassisted application of the material. This article discusses issues that arise in the application of homework tasks with a child population (e.g., compliance). Homework in both child- and family-focused treatment is discussed. The issues addressed regarding homework, although raised in the context of anxious children in a cognitive behavioral treatment program, may be broadly applied to children in psychotherapy. © 2002 Wiley Periodicals, Inc. J Clin Psychol/In Session 58: 525,534, 2002. [source] Dosage regimens for inhaled therapy in children should be reconsideredJOURNAL OF PAEDIATRICS AND CHILD HEALTH, Issue 2 2002JH Wildhaber Abstract: In current asthma guidelines, dosage regimens for inhalation therapy in children are based on adult doses and are generally titrated per kilogram of bodyweight or per square metre of body surface area. However, these recommendations do not correspond well with current knowledge of aerosol therapy in childhood. Lung deposition of the aerosolised drug is the key determinant for clinical efficacy and for systemic side effects of inhalation therapy. Lung deposition increases with age, whereas lung deposition expressed as a percentage per kilogram bodyweight is age-independent. This finding is explained by the self-regulating effect of age-dependent airway anatomy on lung deposition. Therefore, it is more likely that adult doses translate into paediatric doses only by virtue of the differences in self-limiting pulmonary deposition when using the same absolute nominal doses of the medication. Adapting the adult dose to a paediatric dose calculated on body size might be unnecessary and could lead to insufficient pulmonary deposition of medication. These findings suggest that dosage regimens for inhalation therapy for children may have to be reconsidered, and should be determined from dose-ranging studies rather than calculated from adult doses based on body size. [source] Narrative exposure therapy for 7- to 16-year-olds: A randomized controlled trial with traumatized refugee children,JOURNAL OF TRAUMATIC STRESS, Issue 4 2010Martina Ruf The authors examined the effectiveness of narrative exposure therapy for children (KIDNET) in treating posttraumatic stress disorder (PTSD) in refugee children living in exile. Twenty-six children traumatized by organized violence were randomly assigned to KIDNET or to a waiting list. Significant treatment by time interactions on all PTSD-relevant variables indicated that the KIDNET group, but not the controls, showed a clinically significant improvement in symptoms and functioning. Success of the KIDNET group remained stable at 12-month follow-up. This study confirms previous findings that, if left untreated, PTSD in children may persist for an extended period. However, it also shows that it is possible to effectively treat chronic PTSD and restore functioning in traumatized refugee children in only 8 treatment sessions. [source] Childhood multifocal acquired demyelinating sensory and motor neuropathyMUSCLE AND NERVE, Issue 6 2008Hiroyuki Wakamoto MD Abstract We report the first pediatric cases of multifocal acquired demyelinating sensory and motor neuropathy with electrophysiologic evidence of proximal conduction abnormalities but no definite conduction block. Intravenous immunoglobulin caused clinical improvement followed by long-term remission without maintenance therapy; one patient has exhibited a monophasic course and the other has had a single relapse during the last 5 years. These cases suggest that there may be a long-term sustained beneficial effect of intravenous immunoglobulin therapy for children with this neuropathy. Muscle Nerve, 2008 [source] The application of client-centred occupational therapy for Korean children with developmental disabilities,OCCUPATIONAL THERAPY INTERNATIONAL, Issue 4 2008Dae Hyuk Kang Abstract The aim of this paper was to investigate the effectiveness of client-centred occupational therapy using the Canadian Occupational Performance Measure (COPM) and the Assessment of Motor and Process Skills (AMPS). Eight girls and 23 boys from Korea, with developmental disabilities and from 3 to 10 years of age participated in this study. Each child participated in 20 to 24 sessions of client-centred occupational therapy. Both the COPM and the AMPS change scores demonstrated statistically significant improvement (p < 0.01) in occupational performance. Significant correlations were found between COPM , Performance and AMPS , Motor skills (rs = 0.64, p < 0.05), and COPM , Satisfaction and AMPS , Process skills (rs = 0.62, p < 0.05) in a group positive towards client-centred occupational therapy. The COPM was a valuable tool in guiding and measuring the client-centred occupational therapy for children with developmental disabilities. The small sample size of 31 children limits the generalizability of the study's results. Future research needs to use a larger and more diverse sample of children to further validate the effectiveness of client-centred occupational therapy. Copyright © 2008 John Wiley & Sons, Ltd. [source] What do young school-age children know about occupational therapy?OCCUPATIONAL THERAPY INTERNATIONAL, Issue 4 2001An evaluation study Abstract Occupational therapy is a poorly understood profession. In response to this fact, the American Occupational Therapy Association has launched a national campaign to increase awareness of occupational therapy among adults. Little is known, however, about children's perceptions of occupational therapy. The current evaluation study reports on the assessment of children's perceptions of occupational therapy prior to, and following, an interactive demonstration on occupational therapy as part of a larger neuroscience exposition. One hundred and three elementary school-aged children (55 boys and 48 girls) from local schools attended a one-day neuroscience exposition held at the Boys & Girls Clubs of Omaha. At three of 18 booths at the exposition, occupational therapy faculty and students explained what occupational therapists do, and demonstrated the link between brain function and occupational performance. Children completed pre and post questionnaires. Results revealed that on pre-test, the vast majority of participants could not answer the question or had no idea of what occupational therapists do. On post-test, 75% reported that they had knowledge of what occupational therapists do. These preliminary findings suggest that a campaign of public awareness about occupational therapy for children would be highly effective and beneficial, and that a neuroscience exposition including occupational therapy is one effective intervention to promote such awareness. Copyright © 2001 Whurr Publishers Ltd. [source] Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseasesPEDIATRIC BLOOD & CANCER, Issue 1 2008Prakash Satwani MD Abstract Allogeneic hematopoietic stem cell transplant (AlloSCT) from related or unrelated histocompatible donors has been well established as potentially curative therapy for children and adolescents with selected malignant and non-malignant diseases. In the malignant setting non-myeloablative (NMA)/reduced intensity (RI)-AlloSCT eradicates malignant cells through a graft versus malignancy effect provided by alloreactive donor T-lymphocytes and/or natural killer cells. In patients with non-malignant diseases NMA/RI AlloSCT provides enough immunosuppression to promote engraftment and correct underlying genetic defects. In children, myeloablative AlloSCT is not only associated with acute short-term toxicities but also long-term late complications such as growth retardation, infertility, and secondary malignancies. NMA/RI-AlloSCT in children may be associated with reduction in use of blood products, risk of infections, transplant-related mortality, and length of hospitalization. Despite the success of RI-AlloSCT in adults, large prospective and/or randomized multicenter studies are necessary in children and adolescent recipients to define the appropriate patient population, optimal conditioning regimens, cost-benefits, survival and differences in short-term and long-term effects compared to conventional myeloablative conditioning. Pediatr Blood Cancer 2008;50:1,8. © 2007 Wiley-Liss, Inc. [source] Practitioner Review: The effectiveness of systemic family therapy for children and adolescentsTHE JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY AND ALLIED DISCIPLINES, Issue 5 2002David Cottrell Background: Systemic family therapy has become a widely used intervention in child and adolescent mental health services over the last twenty years. Methods: This paper reviews the development of systemic family therapy, briefly describes the theory and techniques associated with the most prominent contemporary strands of systemic practice, and examines the empirical justification for using systemic family therapies with children and adolescents. Results: There is a paucity of well-designed randomised controlled trials of systemic therapies with children and adolescents and those trials that do exist evaluate older structural and strategic therapies. Methodological limitations of existing research include the use of unrepresentative participants, small sample sizes and wide age ranges. There is a lack of credible no-treatment or alternative treatment controls, tests of clinical as opposed to statistical significance, and conceptually relevant outcome measures that examine underlying interactional mechanisms. The term `family therapy' encompasses a wide range of interventions and it is not always clear what treatment intervention has been delivered. Nevertheless, there is good evidence for the effectiveness of systemic family therapies in the treatment of conduct disorders, substance misuse and eating disorders, and some support for their use as second-line treatments in depression and chronic illness. Conclusions: Systemic family therapy is an effective intervention for children and adolescents but further well-designed outcome studies are needed using clearly specified, manualised forms of treatment and conceptually relevant outcome measures. [source] Practitioner Review: Treatment of Obsessive-Compulsive Disorder in Children and AdolescentsTHE JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY AND ALLIED DISCIPLINES, Issue 4 2000Judith L. Rapoport This paper reviews the treatment of obsessive-compulsive disorder (OCD) in children and adolescents. Focusing on clinical features of the disorder and its treatment particular to pediatric onset, diagnosis, assessment, and behavioral, pharmacological, as well as new investigative treatments are covered. Adaptation of cognitive-behavioral therapy for children and adolescents, use of augmenting agents in drug treatment, and subtyping of OCD cases are developments relevant for current practice. [source] Correction of mucopolysaccharidosis type IIIA somatic and central nervous system pathology by lentiviral-mediated gene transferTHE JOURNAL OF GENE MEDICINE, Issue 9 2010Chantelle McIntyre Abstract Background The hallmark of lysosomal storage disorders (LSDs) is microscopically demonstrable lysosomal distension. In mucopolysaccharidosis type IIIA (MPS IIIA), this occurs as a result of an inherited deficiency of the lysosomal hydrolase sulphamidase. Consequently, heparan sulphate, a highly sulphated glycosaminoglycan, accumulates primarily within the cells of the reticulo-endothelial and monocyte-macrophage systems and, most importantly, neurones. Children affected by MPS IIIA experience a severe, progressive neuropathology that ultimately leads to death at around 15 years of age. Methods MPS IIIA pathology was addressed in a mouse model using two separate methods of therapeutic gene delivery. A lentiviral vector expressing murine sulphamidase was delivered to 6-week-old MPS IIIA affected mice either by intravenous injection, or by intraventricular infusion. Therapeutic outcomes were assessed 7 months after gene transfer. Results After intravenous gene delivery, liver sulphamidase was restored to approximately 30% of wild-type levels. The resultant widespread delivery of enzyme secreted from transduced cells to somatic tissues via the peripheral circulation corrected most somatic pathology. However, unlike an earlier study, central nervous system (CNS) pathology remained unchanged. Conversely, intraventricular gene delivery resulted in widespread sulphamidase gene delivery in (and reduced lysosomal storage throughout) the brain. Improvements in behaviour were observed in these mice, and interestingly, pathological urinary retention was prevented. Conclusions The CNS remains the last major barrier to effective therapy for children affected by LSDs. The blood,brain barrier (BBB) limits the uptake of lysosomal enzymes from the peripheral circulation into the CNS, making direct gene delivery to the brain a reasonable, albeit more challenging, therapeutic option. Future work will further assess the relative advantages of directly targeting the brain with somatic gene delivery with sulphamidase modified to increase the efficiency of transport across the BBB. Copyright © 2010 John Wiley & Sons, Ltd. [source] Home programmes in paediatric occupational therapy for children with cerebral palsy: Where to start?AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL, Issue 4 2006Iona Novak Aim:, Home programmes are used extensively for children with cerebral palsy. Even though there is consensus about the importance of home programme intervention, there is little evidence of efficacy and scant information regarding programme characteristics that might affect family participation. Instead, research to date has focussed on parental compliance with prescribed programmes and parent,child interactions. Methods:, Based on reviewed literature, this article proposes a model to guide development of home programmes for children with cerebral palsy. It is a starting point for therapists to consider the way in which they focus and structure their home programmes for children who have cerebral palsy. Results and Conclusions:, The paper identifies an urgent need to develop clinical guidelines for home programmes through rigorous formal processes and to evaluate the impact of occupational therapy home programmes. [source] Home-based therapy for oedematous malnutrition with ready-to-use therapeutic foodACTA PAEDIATRICA, Issue 8 2006Michael A. Ciliberto Abstract Background: Standard recommendations are that children with oedematous malnutrition receive inpatient therapy with a graduated feeding regimen. Aim: To investigate exclusive home-based therapy for children with oedematous malnutrition. Methods: Children with oedematous malnutrition, good appetite and no complications were treated at home with ready-to-use therapeutic food (RUTF) and followed up fortnightly for up to 8 wk. Setting and participants: 219 children aged 1,5 y with oedema enrolled in one of two therapeutic nutritional studies in Malawi in 2003,2004. Results: The overall recovery rate was 83% (182/219), and the case-fatality rate was 5% (11/219). For children with wasting and oedematous malnutrition, 65% (55/85) recovered and 7% (6/85) died. The average weight gain was 2.8±3.2 g/kg/d (mean±SD). Conclusion: This preliminary observation suggests that children with oedematous malnutrition and good appetite may be successfully treated with home-based therapy; a randomized, controlled trial to evaluate this is warranted. [source] | |||||||||||||||||||||||||